Home > Products > EGFR & MET
> Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (scIgG)
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (scIgG) (CAT#: SCIGG-154)
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-EGFR and anti-MET IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Colorectal cancer; Pancreatic cancer; Head and neck cancer; Non-small cell lung cancer (NSCLC) therapy.
There are currently no customer reviews or questions for Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (scIgG) (SCIGG-154). Click the button below to contact us or submit your feedback about this product.